News & Events

• June 28, 2021
  

  REQUEST FOR PROPOSAL: OMOP CDM Mapping, Training, and Consulting

  C-Path’s Data Collaboration Center’s Data Science Team is seeking proposals from U.S.-based vendors to provide expertise and on-demand services related to the Observational Health Data Sciences and Informatics (OHDSI) Observational Medical Outcomes Partnership (OMOP) Common Data Model (CDM) for our rare disease data sharing platform, the Rare Disease Cures Accelerator-Data and Analytics Platform (RDCA-DAP). We......
• May 19, 2021
  

  ERA4TB Update

  NEWSLETTER: The ERA4TB (European Regimen Accelerator for Tuberculosis) project, a public-private initiative devoted to accelerating the development of new treatment regimens for tuberculosis, issued its first newsletter this month which includes updates on the project thus far. Read the full communication and subscribe, here: https://era4tb.org/newsletter.

• May 18, 2021
  

  C-Path Request for Proposal for External Communications

  Critical Path Institute (C-Path) is seeking a proposal, including timelines and budget, for external marketing, communications, public relations and related services. C-Path Request for Proposal for External Communications...
• April 22, 2021
  

  Data Collaboration Center Request for Proposal

  RFP: The RDCA Branding & Web Portal Data Collaboration Center’s (DCC’s) platform development team is seeking a proposal, including timelines and budget, to build a user portal for our rare disease data sharing platform – Rare Disease Cures Accelerator-Data and Analytics Platform (RDCA-DAP).   RFP: RDCA Branding & Web Portal...
• April 14, 2021
  

  CPTA Welcomes Triplet Therapeutics Chief Medical Officer as Industry Co-Director

  C-Path’s Critical Path to Therapeutics for the Ataxias Consortium is pleased to announce the appointment of Irina Antonijevic, M.D., Ph.D., as the consortium’s Industry Co-Director. Irina has worked in drug development for over 18 years, with a focus on translational medicine and early development in neuroscience, but also ophthalmology and immunology. She has gained experience......